UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.355

Sortiert nach

Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma

Stem cells (Dayton, Ohio), 2008-03, Vol.26 (3), p.831-841

2008

Volltextzugriff (PDF)

The Spanish Caribbean Confederation: Modern Subjectivities and a Rhetoric of Failure

Small axe : a journal of criticism, 2020-03, Vol.24 (1), p.53-60

Rivera, Ángel A.

2020

Volltextzugriff (PDF)

Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer

PloS one, 2011-10, Vol.6 (10), p.e25131-e25131

2011

Volltextzugriff (PDF)

Promotion of incisional wound repair by human mesenchymal stem cell transplantation

Experimental dermatology, 2009-04, Vol.18 (4), p.362-369

2009

Volltextzugriff (PDF)

Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma

Human gene therapy, 2007-07, Vol.18 (7), p.589

2007

Volltextzugriff (PDF)

Comparative evaluation of survivin, midkine, and CXCR4 promoters for transcriptional targeting of glioma gene therapy

Cancer biology & therapy, 2007-05, Vol.6 (5), p.679-685

2007

Volltextzugriff (PDF)

The human survivin promoter : a novel transcriptional targeting strategy for treatment of glioma

Journal of neurosurgery, 2006-04, Vol.104 (4), p.583-592

2006

Volltextzugriff (PDF)

F5‐Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV‐short production

Journal of thrombosis and haemostasis, 2021-07, Vol.19 (7), p.1653-1665

2021

Volltextzugriff (PDF)

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach

Virology journal, 2008-08, Vol.5 (1), p.98-98, Article 98

2008

Volltextzugriff (PDF)

Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures

Molecular cancer therapeutics, 2004-04, Vol.3 (4), p.437-449

2004

Volltextzugriff (PDF)

Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism

Cancer biology & therapy, 2003-09, Vol.2 (5), p.511-515

2003

Volltextzugriff (PDF)

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

Breast cancer research and treatment, 2007-10, Vol.105 (2), p.157-167

2007

Volltextzugriff (PDF)

Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy

Molecular cancer therapeutics, 2010-09, Vol.9 (9), p.2536-2544

2010

Volltextzugriff (PDF)

The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy

The journal of gene medicine, 2003-04, Vol.5 (4), p.300-310

2003

Volltextzugriff (PDF)

Novel Infectivity-Enhanced Oncolytic Adenovirus with a Capsid-Incorporated Dual-Imaging Moiety for Monitoring Virotherapy in Ovarian Cancer

Molecular imaging, 2009-09, Vol.8 (5), p.264-277

2009

Volltextzugriff (PDF)

Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system

Cancer biology & therapy, 2005-11, Vol.4 (11), p.1203-1210

2005

Volltextzugriff (PDF)

Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds

Wound repair and regeneration, 2006-09, Vol.14 (5), p.608-617

2006

Volltextzugriff (PDF)

Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo

Cancer biology & therapy, 2006-12, Vol.5 (12), p.1647-1653

2006

Volltextzugriff (PDF)

Conditionally Replicating Adenovirus Expressing TIMP2 for Ovarian Cancer Therapy

Clinical cancer research, 2011-02, Vol.17 (3), p.538-549

2011

Volltextzugriff (PDF)

Increased Plasma Chymase Concentration and Mast Cell Chymase Expression in Venous Neointimal Lesions of Patients with CKD and ESRD

Seminars in dialysis, 2011-11, Vol.24 (6), p.688-693

2011

Volltextzugriff (PDF)

Novel oncolytic adenoviruses targeted to melanoma: Specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter

Cancer research (Chicago, Ill.), 2002-08, Vol.62 (16), p.4663-4670

2002

Volltextzugriff (PDF)

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

The lancet respiratory medicine, 2021-12, Vol.9 (12), p.1407-1418

2021

Volltextzugriff (PDF)

A Tumor-stroma Targeted Oncolytic Adenovirus Replicated in Human Ovary Cancer Samples and Inhibited Growth of Disseminated Solid Tumors in Mice

Molecular therapy, 2012-12, Vol.20 (12), p.2222-2233

2012

Volltextzugriff (PDF)

Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model

Laboratory investigation, 2013-03, Vol.93 (3), p.268-278

2013

Volltextzugriff (PDF)

Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells

Journal of neurosurgery, 2007-09, Vol.107 (3), p.617-627

2007

Volltextzugriff (PDF)

1 – 25 von 2.355

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.861)
Mit Volltextzugriff
(2.137)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(58)
... seit 30 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma

The Spanish Caribbean Confederation: Modern Subjectivities and a Rhetoric of Failure

Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer

Promotion of incisional wound repair by human mesenchymal stem cell transplantation

Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma

Comparative evaluation of survivin, midkine, and CXCR4 promoters for transcriptional targeting of glioma gene therapy

The human survivin promoter : a novel transcriptional targeting strategy for treatment of glioma

F5‐Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV‐short production

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach

Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures

Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy

The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy

Novel Infectivity-Enhanced Oncolytic Adenovirus with a Capsid-Incorporated Dual-Imaging Moiety for Monitoring Virotherapy in Ovarian Cancer

Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system

Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds

Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo

Conditionally Replicating Adenovirus Expressing TIMP2 for Ovarian Cancer Therapy

Increased Plasma Chymase Concentration and Mast Cell Chymase Expression in Venous Neointimal Lesions of Patients with CKD and ESRD

Novel oncolytic adenoviruses targeted to melanoma: Specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

A Tumor-stroma Targeted Oncolytic Adenovirus Replicated in Human Ovary Cancer Samples and Inhibited Growth of Disseminated Solid Tumors in Mice

Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model

Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells

Suchergebnisse filtern